This Analyst Sees Recovery For PolyPid Despite Failed Phase 3 Readout
Raymond James downgraded PolyPid Ltd (NASDAQ:PYPD) from Strong Buy to Outperform post SHIELD I Phase 3 results that, despite consistency and evidence of…
Athira Outlines Possible Comeback For Alzheimer’s Candidate
Athira Pharma Inc (NASDAQ:ATHA) announced an update to its plans for the ongoing LIFT-AD trial of fosgonimeton (ATH-1017) for mild-to-moderate Alzheimer’s…
FDA Again Highlights Lacking Data From Amylyx’s Amyotrophic Lateral Sclerosis Candidate
The FDA released briefing documents for Amylyx Pharmaceuticals Inc’s (NASDAQ:AMLX) experimental amyotrophic lateral sclerosis drug, as a second adcomm is scheduled…
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
The European Union’s drugs regulator is just a few weeks away from deciding whether to approve Sanofi SA (NASDAQ:SNY) and GSK…
Alaunos Therapeutics Touts Early Clinical Response For Its Cancer Cell Therapy
Alaunos Therapeutics Inc (NASDAQ:TCRT) announced early clinical findings from its ongoing TCR-T Library Phase 1/2 trial. “We are excited to announce…
Ironwood’s Constipation Drug Shows Efficacy In Pediatric Patients
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) announced topline data from a Phase 3 trial evaluating Linzess (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation.
Top Financial Stories Tuesday, September 6: Focus on iPhone 14 Event, OPEC+ Plans Mild Production Cut, Netflix Says No To Crypto Ads And More…
Reuters
EQT Corp Close To Buying THQ Appalachia
European Commission Says No To Illumina-Grail Deal – What’s Next?
The European Commission has prohibited Illumina Inc’s (NASDAQ:ILMN) acquisition of GRAIL. The company is reviewing the Commission’s order and intends to…
Sanofi-Regeneron’s Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) announced results from a Phase 3 open-label extension trial of Dupixent (dupilumab) as maintenance therapy…
Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy
In its SEC filing, Allena Pharmaceuticals Inc (NASDAQ:ALNA) filed for chapter 11 bankruptcy protection and terminated the employment of substantially…